Gyorgy Domány

Title: **Gyorgy Domány: Innovator in NMDA Receptor Antagonists**

Introduction

Gyorgy Domány is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmacology through his innovative research and development of novel compounds. With a strong focus on NMDA receptor antagonists, Domány's work has the potential to impact therapeutic strategies in various neurological conditions.

Latest Patents

Domány holds a patent for "Piperidine derivatives as NMDA receptor antagonists." This invention relates to a specific compound of formula (I), where V and U can be hydrogen, halogen, C-Calkylamino, or can form a group with one or more heteroatoms. This patent signifies a breakthrough in the development of pharmaceuticals aimed at modulating NMDA receptor activity.

Career Highlights

Currently, Gyorgy Domány is associated with Gedeon Richter Vegyeszeti Gyár Rt., a well-respected company in the pharmaceutical industry. His expertise and innovative mindset have contributed to the company's efforts in advancing therapeutic solutions. With a single patent under his name, Domány showcases his ability to translate scientific research into tangible inventions that hold potential for medical application.

Collaborations

Throughout his career, Domány has collaborated with several esteemed colleagues, including Csilla Horváth and Gizella Bartáné Szalai. These collaborations have played an essential role in enhancing the research and development processes, fostering an environment of innovation and creativity in their projects.

Conclusion

Gyorgy Domány exemplifies the spirit of innovation within the pharmaceutical field, particularly through his focus on NMDA receptor antagonists. As he continues his work at Gedeon Richter Vegyeszeti Gyár Rt., his contributions will likely pave the way for new therapeutic advancements, underscoring the importance of inventors in the healthcare domain.